Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Finn

Showing results (211-220 of 235) with videos related to

Pageof 24
Sort By:
Vaccine|August 31, 2011
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccinesNick J Andrews, Woolf T Walker, Adam Finn, et al.
The Journal of Infection|June 19, 2022
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adultsRajeka Lazarus, Christian Taucher, Claire Brown, et al.
Health Technology Assessment (Winchester, England)|September 2, 2017
Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility studyHans de Graaf, Priya Sukhtankar, Barbara Arch, et al.
Cell Reports. Medicine|June 14, 2021
Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2Anu Goenka, Alice Halliday, Michaela Gregorova, et al.
The Journal of Infection|February 25, 2015
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategyCatherine A Jeppesen, Matthew D Snape, Hannah Robinson, et al.
Elife|December 17, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumoniaMichaela Gregorova, Daniel Morse, Tarcisio Brignoli, et al.
The Journal of Infectious Diseases|May 20, 2025
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) ParticipantsHolly E Baum, Marianna Santopaolo, Ore Francis, et al.
Lancet (London, England)|November 14, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trialRajeka Lazarus, Sarah Baos, Heike Cappel-Porter, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Pageof 24

Showing results (211-220 of 235) with videos related to

Sort By:
Pageof 24
Vaccine|August 31, 2011
Predictors of immune response and reactogenicity to AS03B-adjuvanted split virion and non-adjuvanted whole virion H1N1 (2009) pandemic influenza vaccinesNick J Andrews, Woolf T Walker, Adam Finn, et al.
The Journal of Infection|June 19, 2022
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adultsRajeka Lazarus, Christian Taucher, Claire Brown, et al.
Health Technology Assessment (Winchester, England)|September 2, 2017
Duration of intravenous antibiotic therapy for children with acute osteomyelitis or septic arthritis: a feasibility studyHans de Graaf, Priya Sukhtankar, Barbara Arch, et al.
Cell Reports. Medicine|June 14, 2021
Young infants exhibit robust functional antibody responses and restrained IFN-γ production to SARS-CoV-2Anu Goenka, Alice Halliday, Michaela Gregorova, et al.
The Journal of Infection|February 25, 2015
Meningococcal carriage in adolescents in the United Kingdom to inform timing of an adolescent vaccination strategyCatherine A Jeppesen, Matthew D Snape, Hannah Robinson, et al.
Elife|December 17, 2020
Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumoniaMichaela Gregorova, Daniel Morse, Tarcisio Brignoli, et al.
The Journal of Infectious Diseases|May 20, 2025
Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) ParticipantsHolly E Baum, Marianna Santopaolo, Ore Francis, et al.
Lancet (London, England)|November 14, 2021
Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trialRajeka Lazarus, Sarah Baos, Heike Cappel-Porter, et al.
Lancet (London, England)|August 23, 2014
Effect of a quadrivalent meningococcal ACWY glycoconjugate or a serogroup B meningococcal vaccine on meningococcal carriage: an observer-blind, phase 3 randomised clinical trialRobert C Read, David Baxter, David R Chadwick, et al.
Lancet (London, England)|July 24, 2020
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trialPedro M Folegatti, Katie J Ewer, Parvinder K Aley, et al.
Pageof 24